These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 2472098)
21. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays. Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569 [TBL] [Abstract][Full Text] [Related]
22. Aldehyde dehydrogenase (ALDH) 3A1 expression by the human keratocyte and its repair phenotypes. Pei Y; Reins RY; McDermott AM Exp Eye Res; 2006 Nov; 83(5):1063-73. PubMed ID: 16822507 [TBL] [Abstract][Full Text] [Related]
23. Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killing. Salata RA; Kleinhenz ME; Schacter BZ; Ellner JJ Cancer Res; 1984 Mar; 44(3):1044-7. PubMed ID: 6607107 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro. Ware CF; Granger GA J Immunol; 1981 May; 126(5):1919-26. PubMed ID: 6452481 [TBL] [Abstract][Full Text] [Related]
26. Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy. Mier JW; Brandon EP; Libby P; Janicka MW; Aronson FR J Immunol; 1989 Oct; 143(7):2407-14. PubMed ID: 2528594 [TBL] [Abstract][Full Text] [Related]
27. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum. Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047 [TBL] [Abstract][Full Text] [Related]
28. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258 [TBL] [Abstract][Full Text] [Related]
29. Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts. Ljunggren HG; Ohlén C; Höglund P; Yamasaki T; Klein G; Kärre K J Immunol; 1988 Jan; 140(2):671-8. PubMed ID: 3335786 [TBL] [Abstract][Full Text] [Related]
30. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity. Luger TA; Uchida A; Köck A; Colot M; Micksche M J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831 [TBL] [Abstract][Full Text] [Related]
31. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Gan X; Zhang L; Solomon GF; Bonavida B Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684 [TBL] [Abstract][Full Text] [Related]
32. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro. Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577 [TBL] [Abstract][Full Text] [Related]
33. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989 [TBL] [Abstract][Full Text] [Related]
34. [Antibody-dependent cell cytotoxicity and spontaneous cytotoxicity of peripheral blood lymphocytes of organ recipients and cells infiltrating the kidney allogeneic transplant]. Drannik GN; Baran EIa; Seniuk OF; Driianskaia VE Fiziol Zh (1978); 1989; 35(5):68-72. PubMed ID: 2591583 [TBL] [Abstract][Full Text] [Related]
35. Differences in leukocyte phenotype and interferon-gamma expression in stroma and endothelium during corneal graft rejection. Nicholls SM; Banerjee S; Figueiredo FC; Crome S; Mistry S; Easty DL; Dick AD Exp Eye Res; 2006 Aug; 83(2):339-47. PubMed ID: 16616741 [TBL] [Abstract][Full Text] [Related]
36. Long-term killing of natural killer-resistant target cells by interferon-alpha-, interferon-gamma-, and interleukin-2-activated natural killer cells. Sarzotti M; Klimpel GR; Baron S Nat Immun Cell Growth Regul; 1989; 8(2):66-75. PubMed ID: 2503715 [TBL] [Abstract][Full Text] [Related]
37. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. Howell DN; Andreotti PE; Dawson JR; Cresswell P J Immunol; 1985 Feb; 134(2):971-6. PubMed ID: 3871222 [TBL] [Abstract][Full Text] [Related]
38. Lymphokine-activated and natural killer cell activity in human intestinal mucosa. Hogan PG; Hapel AJ; Doe WF J Immunol; 1985 Sep; 135(3):1731-8. PubMed ID: 3926882 [TBL] [Abstract][Full Text] [Related]
39. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor. Uchida A; Moore M J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944 [TBL] [Abstract][Full Text] [Related]
40. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells. Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]